Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Prieto, J. (Jesús) | - |
dc.creator | Herraiz-Bayod, M.J. (Maite J.) | - |
dc.creator | Sangro, B. (Bruno) | - |
dc.creator | Qian, C. (Cheng) | - |
dc.creator | Mazzolini, G. (Guillermo) | - |
dc.creator | Melero, I. (Ignacio) | - |
dc.creator | Ruiz, J. (Juan) | - |
dc.date.accessioned | 2012-04-25T07:50:32Z | - |
dc.date.available | 2012-04-25T07:50:32Z | - |
dc.date.issued | 2003 | - |
dc.identifier.citation | Prieto J, Herraiz M, Sangro B, Qian C, Mazzolini G, Melero I, et al. The promise of gene therapy in gastrointestinal and liver diseases. Gut 2003 May;52 Suppl 2:ii49-54. | es_ES |
dc.identifier.issn | 1468-3288 | - |
dc.identifier.uri | https://hdl.handle.net/10171/21785 | - |
dc.description.abstract | Gene therapy consists of the transfer of genetic material to cells to achieve a therapeutic goal. In the field of gastroenterology and hepatology gene therapy has produced considerable expectation as a potential tool in the management of conditions that lack effective therapy including non-resectable neoplasms of the liver, pancreas and gastrointestinal tract, chronic viral hepatitis unresponsive to interferon therapy, liver cirrhosis, and inflammatory bowel disease. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | British Society of Gastroenterology (BSG) | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Gastrointestinal Diseases/therapy | es_ES |
dc.subject | Gene Therapy/methods | es_ES |
dc.subject | Liver Diseases/therapy | es_ES |
dc.title | The promise of gene therapy in gastrointestinal and liver diseases | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherversion | http://gut.bmj.com/content/52/suppl_2/ii49 | es_ES |
dc.type.driver | info:eu-repo/semantics/article | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.